Please login to the form below

Not currently logged in
Email:
Password:

Lucid expands with launch of new strategic consultancy

Its new company will be led by Duncan Ferguson

Lucid Strategic Consultancy Duncan Ferguson

The Lucid Group has expanded its operations with the launch of a new consultancy and appointed Duncan Ferguson (pictured above) to lead the venture.

Lucid Strategic Consultancy will provide a range of strategic consultancy services, covering areas such as early pipeline development, brand launch and mature product planning.

Ferguson, its new managing director, joins Lucid from LEO Pharma, where he spent seven years, most recently serving as its senior vice president of global commercial strategy.

Prior to that he worked at Abbott Laboratories, holding senior UK and international marketing roles.

Ferguson said: ““I’m passionate about inspiring others to make a sustainable impact with their strategy development and implementation. I have worked with Lucid for several years, and see a perfect fit for myself within this exciting company.

“I have experienced the true challenges faced by leaders and brand teams, so I know where the gaps in pharma are and what it takes to make a difference.”

Lucid said its new consultancy would offer “a new way of thinking, called momentum strategy” to generate commercial value that was developed following intensive research of some of the world’s most successful consumer brands.

Article by
Dominic Tyer

9th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell - Cake

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics